Journal ArticleUnknown
Single-Dose Azithromycin for the Treatment of Cholera in Adults
Authors
Author Affiliations
International Centre for Diarrhoeal Disease Research, University of Oxford, University of KwaZulu-Natal
Published InNew England Journal of Medicine
Year2006
Citations175
Abstract
BACKGROUND: Single-dose azithromycin is effective in the treatment of severe cholera in children, but its effectiveness in adults has not been evaluated. METHODS: We conducted a double-blind, randomized trial comparing the equivalence of azithromycin and ciprofloxacin (each given in a single 1-g dose of two 500-mg tablets) among 195 men with severe cholera caused by Vibrio cholerae O1 or O139. Patients were hospitalized for five days. A stool culture was performed daily. Primary outcome measures were clinical success (the cessation of watery stools within 48 hours after drug administration) and bacteriologic success (the inability to isolate V. cholerae after 48 hours). RESULTS: Therapy was clinically successful in 71 of 97 patients receiving azithromycin (73 percent) and in 26 of 98…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.